Skip to main content
. 2015 Mar 23;5(1):98–117. doi: 10.3390/bios5010098

Table 1.

Various combinations of the candidate antibodies selected for the two steps.

Antibody on MNPs Antibody on Gold Nanoslits Retention Rate * (%)
Anti-EGFR Anti-CD44 100
Anti-EGFR Anti-EphA2 (3F7) 60
Anti-EphA2 (3F7) Anti-EGFR 9
Anti-EphA2 (3F7) Anti-CD44 100

* Percentage of cells retained on the gold nanoslits.